Utama › Keadaan Pasca-COVID (Long COVID)
Kajian klinikal Keadaan Pasca-COVID (Long COVID) sedang mengambil peserta di AS
118 kajian untuk Keadaan Pasca-COVID (Long COVID) sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY15 kajian
- Houston, TX13 kajian
- Boston, MA13 kajian
- Baltimore, MD12 kajian
- Chicago, IL11 kajian
- Washington, DC10 kajian
- San Francisco, CA8 kajian
- Atlanta, GA8 kajian
- Durham, NC8 kajian
- San Diego, CA7 kajian
- Los Angeles, CA6 kajian
- Hialeah, FL6 kajian
- Miami, FL6 kajian
- Pittsburgh, PA6 kajian
- Salt Lake City, UT6 kajian
- Columbus, OH5 kajian
- Dallas, TX5 kajian
- Mountain View, CA4 kajian
- St. Louis, MO4 kajian
- Louisville, KY4 kajian
- Tampa, FL4 kajian
- San Antonio, TX4 kajian
- Seattle, WA4 kajian
- Cincinnati, OH4 kajian
- Birmingham, AL4 kajian
- Nashville, TN4 kajian
- Austin, TX3 kajian
- Sacramento, CA3 kajian
- Homestead, FL3 kajian
- Kendall, FL3 kajian
- St. Petersburg, FL3 kajian
- Charleston, SC3 kajian
- Omaha, NE3 kajian
- Boise, ID3 kajian
- Warren, MI3 kajian
- The Woodlands, TX3 kajian
- Portland, OR3 kajian
- New Orleans, LA3 kajian
- New Haven, CT3 kajian
- Philadelphia, PA3 kajian
Mengikut negeri
- Alabama7 kajian
- Arizona4 kajian
- California30 kajian
- Colorado6 kajian
- Connecticut3 kajian
- Florida13 kajian
- Georgia11 kajian
- Idaho3 kajian
- Illinois13 kajian
- Iowa3 kajian
- Kansas3 kajian
- Kentucky6 kajian
- Louisiana7 kajian
- Maryland21 kajian
- Massachusetts13 kajian
- Michigan6 kajian
- Minnesota6 kajian
- Missouri4 kajian
- Nebraska3 kajian
- Nevada4 kajian
- New Jersey3 kajian
- New York18 kajian
- North Carolina10 kajian
- Ohio11 kajian
- Oregon3 kajian
- Pennsylvania11 kajian
- South Carolina4 kajian
- Tennessee8 kajian
- Texas23 kajian
- Utah7 kajian
- Virginia6 kajian
- Washington5 kajian
- Wilayah Columbia4 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450Exercise in Child Health
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 10 hingga 17 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05359991Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06160128SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07021794Long-Term Study of COVID-19 Infection and Long COVID
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07781501Heat thErapy And mobiLity in COVID-19 Survivors
Mengambil peserta
Umur 50 hingga 90 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06928116A Study of COVID-19 Vaccine(s) in Children and Adults
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
Umur 5 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06631287A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06667700A Study to Examine Anktiva for the Treatment of COVID-19.
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07123727A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07743580Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 110 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06577467Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT04887116Viral Infections in Healthy and Immunocompromised Hosts
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
6 Months – 120 Years · Semua jantina · Dikemas kini 14 Sep 2026 · NCT01306084A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07445971Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 100 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT04573062Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
1 Day – 99 Years · Semua jantina · Dikemas kini 9 Sep 2026 · NCT04582903Long-Covid-19 Alleviation Through Learning Mindfulness Study
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT07140094Dime La VerDAD: Verify, Debunk, and Disseminate
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 99 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06417762Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 0 hingga 20 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT04278404Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07770022A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 40 hingga 64 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06810934Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.